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that minocycline mitigates macrophage
recruitment to a peripheral nerve injury
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Background: Minocycline has proven anti-nociceptive effects, but the mechanism by which minocycline delays the
development of allodynia and hyperalgesia after peripheral nerve injury remains unclear. Inflammatory cells, in
particular macrophages, are critical components of the response to nerve injury. Using ultrasmall
superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI) to monitor macrophage trafficking, the
purpose of this project is to determine whether minocycline modulates macrophage trafficking to the site of nerve
injury in vivo and, in turn, results in altered pain thresholds.
Results: Animal experiments were approved by Stanford IACUC. A model of neuropathic pain was created using the
Spared Nerve Injury (SNI) model that involves ligation of the left sciatic nerve in the left thigh of adult Sprague–Dawley
rats. Animals with SNI and uninjured animals were then injected with/without USPIOs (300 μmol/kg IV) and with/without
minocycline (50 mg/kg IP). Bilateral sciatic nerves were scanned with a volume coil in a 7 T magnet 7 days after USPIO
administration. Fluid-sensitive MR images were obtained, and ROIs were placed on bilateral sciatic nerves to quantify
signal intensity. Pain behavior modulation by minocycline was measured using the Von Frey filament test. Sciatic nerves
were ultimately harvested at day 7, fixed in 10% buffered formalin and stained for the presence of iron oxide-laden
macrophages. Behavioral measurements confirmed the presence of allodynia in the neuropathic pain model while the
uninjured and minocycline-treated injured group had significantly higher paw withdrawal thresholds (p< 0.011).
Decreased MR signal is observed in the SNI group that received USPIOs (3.3+/−0.5%) compared to the minocycline-
treated SNI group that received USPIOs (15.2+/−4.5%) and minocycline-treated group that did not receive USPIOs (41.2
+/−2.3%) (p< 0.04). Histology of harvested sciatic nerve specimens confirmed the presence USPIOs at the nerve injury
site in the SNI group without minocycline treatment.
Conclusion: Animals with neuropathic pain in the left hindpaw show increased trafficking of USPIO-laden macrophages
to the site of sciatic nerve injury. Minocycline to retards the migration of macrophages to the nerve injury site, which may
partly explain its anti-nociceptive effects. USPIO-MRI is an effective in vivo imaging tool to study the role of macrophages
in the development of neuropathic pain.
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Macrophages and other monocyte derivatives, as much as
pain-sensing neurons themselves, play a critical role in the
generation of chronic pain conditions. Macrophages are
derived from the myelo-monocytic stem cells in the bone
marrow and play an important role in immunity, inflam-
mation and tissue remodeling. In the setting of nerve in-
jury, macrophages and microglia migrate to various tissues
and, as part of the healing response to injury, elaborate a
variety of inflammatory factors [1]. In an animal model of
peripheral nerve injury, for example, investigators have
found that monocytes migrate into the spinal cord, dorsal
root ganglia and involved spinal nerve roots, and differen-
tiate into macrophages or microglia [2]. Because of their
pro-inflammatory properties, recruitment and activation
of monocyte derivatives to the nervous system is thought
to promote hypersensitivity and chronic pain states.
An in vivo magnetic resonance imaging (MRI)-based
method using magnetic nanoparticles, such as superpara-
magnetic iron-oxide particles (SPIOs), ultrasmall SPIOs
(USPIOs), monocrystalline iron-oxide particles (MIONs)
and cross-linked iron oxide (CLIO) has been developed to
track macrophage and T-cell migration and localization
[3]. Ultrasmall superparamagnetic iron-oxide magnetic
resonance imaging (USPIO-MRI) allows monitoring of
trafficking of macrophages into the central nervous system
in a variety of degenerative neurological conditions [4].
SPIOs have also been used to monitor monocytic/macro-
phage migration patterns in the setting of rheumatoid
arthritis. After intravenous injection of SPIO particles,
cells that reside in the reticuloendothelial system (RES),
including macrophages, engulf the agent. Because macro-
phages are recruited to inflamed joints, monitoring their
distribution by SPIO-based techniques can be helpful, es-
pecially during early phases of the disease. MRI can be
used to study the migration of these cells from the RES to
inflamed joints. Investigators have successfully documen-
ted the migration of SPIO-labeled macrophages to the
synovium of a rat model of RA [5].
Another method to monitor T-cell traffic has been
developed for MRI. T-cells isolated from a subject can be
loaded with dextran-coated SPIO or similar dextran-
coated CLIO [6,7]. When exposed to SPIO, T-cells will
engulf the 30 nm particles by endocytosis. The T-cells are
eventually re-introduced into the subject, and the subject
is scanned. On gradient-echo sequences, cells carrying this
contrast agent appear low in signal intensity owing to the
large susceptibility effect generated by the sequestered
SPIO particles. In rat models of cardiac, renal and lung
allograft rejection, migration of SPIO-labeled T-cells to
the allograft has been found during rejection [8-10].
Using USPIO-MRI as a surrogate marker for macrophage
recruitment, we sought 1) to detect nociception-related
spatiotemporal USPIO-MRI signal changes in a peripheralnerve after injury in vivo- in a longitudinal animal model of
pain, 2) to determine whether chronic pain states correlate
with macrophage recruitment, and 3) to determine whether
USPIO-MR can be used to monitor the known effect of the
antibiotic minocycline on macrophage trafficking to the site
of nerve injury and whether this in turn results in altered
pain thresholds.
Results
Minocycline affects pain behaviors
Minocycline is known to prevent allodynia in both in-
flammatory and mechanical nerve injury models, and
has been shown to decrease macrophage recruitment
after nerve injury [1]. Before testing the impact of this
drug on macrophage trafficking by MR, we first con-
firmed minocycline’s ability to prevent allodynia after
sciatic nerve injury in our model of neuropathic pain.
Behavioral measurements confirmed the presence of
allodynia in the neuropathic pain model (50% paw with-
drawal threshold of 3.86 ± 0.34) while the paw with-
drawal threshold of the minocycline-treated injured
group was significantly higher (4.90 ± 0.08, p< 0.011),
and was similar to the threshold of the uninjured paw
(4.85 ± 0.16). Without minocycline, the injured rat
demonstrated increased sensitivity to previously innocu-
ous stimuli within 72 hours after injury, reaching a plat-
eau within one week. In order to determine the
persistence of the effect of the drug, minocycline admin-
istration was then stopped at this point, one week after
injury. One week after termination of minocycline treat-
ment, all injured rats demonstrated the same level of
allodynia (3.90 ± 0.17 for previously minocycline treated
rats compared to 3.97 ± 0.22 for the untreated rats,
Figure 1).
Minocycline alters trafficking of USPIO-laden
macrophages
We then sought to monitor minocycline’s effect on macro-
phages by labeling these cells in vivo using ultrasmall super-
paramagnetic iron oxide particles. After intravenous
injection, these particles are phagocytosed by reticuloen-
dothelial cells, including macrophages [2]. Delivery of the
particles was confirmed by abdominal MR imaging that
demonstrated a dramatic decline in the T2 weighted signal
intensity of the liver and spleen in animals injected with
USPIOs. On FIESTA MR, the injured sciatic nerve was
enlarged compared to the uninjured nerve, and demon-
strated increased signal intensity relative to muscle (relative
MR signal intensity: 37±1%, Figure 2A). Minocycline treat-
ment alone did not alter the increased signal intensity of
the injured nerve (43±3%). However, with USPIO adminis-
tration, the injured nerves became nearly isointense to the
surrounding muscle (7 ±3%, Figure 2B), suggesting that
USPIO-laden cells had migrated to the site of injury. While
Figure 1 Minocycline administration prevents development of mechanical allodynia after peripheral nerve injury. Mechanical sensitivity
was assessed by the von Frey test before, and 1, 3, 7, 13, 15, and 16 days after nerve injury. The 50% response threshold of the injured left
hindpaw decreased to 3.86 ± 0.34 by 72 hours (squares). The response threshold of rats receiving daily intraperitoneal injections of minocycline
did not change (4.90 ± 0.08, triangles) and was similar to the threshold of the uninjured rats (4.85 ± 0.16, triangles, red line). Minocycline
administration was stopped after seven days; one week later, all injured rats demonstrated the same threshold. Averages and standard deviations
of data collected from 3 – 6 animals at each time point are presented.
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USPIO injections, we further assessed for post-operative
hematomas as a possible confounding source of iron-laden
cells. No hematoma was evident at the site of injury during
the course of imaging. In addition, copious saline washes of
the surgical site did not alter the MR signal properties of
the injured nerve (data not shown). Administration of min-
ocycline significantly reduced the USPIO effect (nerve sig-
nal relative to muscle: 17±5%, Figure 2C, Figure 3,
p< 0.05). In order to determine the etiology of the
decreased MR signal of the injured nerve in rats treated
with USPIOs, rat sciatic nerves were harvested and exam-
ined. Of note, the signal intensity of uninjured right nerve
was only mildly higher than that of surrounding muscle (3
to 7%), which was independent of minocycline and/or
USPIO administration (Figures 2F, Figure 3).
Histologic presence of iron-laden macrophages at the site
of nerve injury is dependent upon minocycline treatment
Histology of these harvested sciatic nerve specimens con-
firmed the presence of iron-laden macrophages at the nerve
injury site only in the group of injured rats that received
USPIOs without minocycline treatment (Figure 4C-F). By
comparison, rats that received minocycline had qualitatively
fewer iron-laden macrophages at the site of nerve injury as
determined by Perl’s staining (Figure 4G, H).
Discussion
After nerve injury, Schwann cells generate inflammatory
chemoattractants that recruit macrophages to the site of
nerve injury, where these cells initiate an inflammatorycascade involving release of cytokines such as monocyte
chemoattractant protein-1 (MCP-1), interleukins, and
nerve growth factor as part of the process of Wallerian de-
generation [11]. However, both centrally and peripherally,
this inflammatory process can result in the development
of neuropathic pain [2].
For example, mutations in mice that result in delayed
or absent macrophage activation, such as knockouts of
the chemokine receptor chemotactic cytokine receptor 2
(CCR2), have impaired neuropathic pain responses [12].
Alternatively, MCP-1 upregulation in the spinal cord is
associated with increased pain hypersensitivity [13]. B7-
H1 (−/−) mice, which possess enhanced macrocytic and
T cell responses to injured peripheral nerves, exhibit
more pronounced mechanical hyperalgesia [14]. Minocy-
cline prevents the development of allodynia, and retards
the migration of macrophages to the nerve injury site.
The mechanism of minocycline action may be due to in-
hibition of matrix metalloproteases and inhibition of
angiogenic factors, thereby preventing breakdown of the
blood-nervous system barrier and revascularization [15].
In our study, animals with neuropathic pain in the
left hindpaw show increased migration of USPIO-
laden macrophages to the site of sciatic nerve injury,
suggesting that USPIO-MRI is an effective tool to
study the role of macrophages in the development of
neuropathic pain. If we could take a picture of an
individual’s pain-sensing circuits and highlight which
foci are associated with abnormal macrophage infil-
tration/microglia activation, this would be invaluable
in helping to objectively diagnose an individual’s
Figure 2 Representative sagittal FIESTA images of the left and right thighs and sciatic nerve of rats with neuropathic pain obtained
7 days following spared nerve injury (SNI). White arrows indicate location of sciatic nerve proximal to the nerve injury. +MINO indicates the
animal received daily intraperitoneal minocycline injections. +USPIO indicates the animal received an intravenous dose of USPIOs immediately
after peripheral nerve injury and on the day prior to MRI. This dose and timing of administration has been shown to label macrophages. The low
signal at the distal truncated end of the nerve corresponds to the site of ligature. A) SNI rat that received neither minocycline nor USPIOs. The
sciatic nerve demonstrates increased signal intensity relative to the surrounding muscle. The injured nerve was enlarged compared to the
uninjured side (data not shown). B) SNI rat that received USPIOs but not minocycline. There is iron-induced signal loss, as the sciatic nerve is
nearly isointense to the surrounding muscle. C) SNI rat that received both minocycline and USPIOs. The signal intensity in the sciatic nerve is
higher than with USPIOs alone, suggesting that minocycline retards the migration of USPIO-laden macrophages to the site of injury..
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cycline’s effect on the development of neuropathic
pain with the effect of minocycline in vivo on
macrophage recruitment suggests a role for this im-
aging tool in pre-clinical development of new drugs
for pain control or in facilitating clinical image-
guided therapies. Although currently not commer-
cially available, iron oxide-based MRI has already
been developed and approved for human use; Feri-
dex©and Combidex© (feroxumide injectable solutions,
AMAG Pharmaceuticals, Inc., Cambridge, MA) have
been available for clinical use, for example. Identify-
ing patients with macrophage infiltration or micro-
glial activation along nociceptive pathways in the
nervous system will help localize and characterize
chronic pain pathways and could promote the use of
analgesic regimens that include macrophage inhibi-
tors such as minocycline.Conclusions
Animals with neuropathic pain in the left hindpaw show
increased trafficking of USPIO-laden macrophages to
the site of sciatic nerve injury. Minocycline appears to
retard the migration of macrophages to the nerve injury
site, which may partly explain its anti-nociceptive effects.
USPIO-MRI is an effective tool to study the role of
macrophages in vivo in the development of neuropathic
pain and, thus, may aid in the development of novel
analgesics and has the potential to be used to study
macrophage behavior and localization in living human
subjects who suffer from chronic pain.
Methods
Animal models
Experiments were carried out using adult Sprague–Dawley
rats weighing 200-250 g. The Peripheral Nerve Injury
Model (Neuropathic Model), otherwise known as the
Figure 3 Percent increase in relative nerve signal intensity in the setting of minocycline and USPIO treatment. The signal intensity of the
injured left and uninjured right sciatic nerve proximal to the site of injury was normalized to that of the adjacent muscle. Asterisks denote injured
left nerve treatment groups that were significantly different from the untreated control animals (Bonferroni’s post hoc multiple comparison test,
p< 0.05 for +USPIO versus +MINO +USPIO; p< 0.001 for +MINO +USPIO and for +USPIO versus -MINO -USPIO; no difference between+MINO and
–MINO -USPIO). The signal intensity of uninjured right nerve was only mildly higher than that of surrounding muscle (3 to 13%), which was
independent of minocycline and/or USPIO administration. Data represent the averages and standard deviations of three animals in each group.
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sistent peripheral neuropathic pain [16]. Briefly, under iso-
flurane anesthesia, the rat left sciatic nerve was exposed
above the trifurcation, and then the tibial and common
peroneal nerves were isolated, ligated, and cut, leaving the
sural nerve intact. These animals develop hyperalgesia and
allodynia within ~3 days after injury.
Ultrasmall paramagnetic iron oxide (USPIO) particle
preparation
Oleate coated iron oxide nanoparticles (15 nm) were
obtained from Ocean NanoTech (Springdale, AR). For sur-
face modification, about 50 mg of oleate coated nanoparti-
cles were dispersed in 10 ml of chloroform. Forty
milligrams of dopamine in 10 ml DMSO were added to the
solution. The mixture was heated at 70 °C for 1 hour, and
then cooled down to room temperature. Hexane was used
to precipitate the nanoparticles, which were then centri-
fuged at 15,000xg for 15 minutes, dried with nitrogen, and
redispersed in DMSO via sonication. The nanoparticles
were added to a solution of 50 mg HSA in borate buffer
(50 nM, pH 8.5), and dialyzed against PBS buffer (pH 7.4)
for 24 h. The nanoparticles were centrifuged at 30,000 g for
20 minutes to remove the free HSA, and were redispersed
in PBS buffer. Small aggregates were removed by passing
the particles through a syringe filter (0.22 μm).
USPIO-magnetic resonance imaging (MRI) and
minocycline treatment
All MRI experiments were performed on a small animal
imaging unit (7.0 T Magnex; GE Medical Systems)located in the Small Animal Center for In-Vivo Imaging
in the Clark Center at Stanford University School of
Medicine. Animals were anesthetized with humidified,
oxygen-enriched 2-4% isoflurane administered via nose
cone. Animals were placed in a rodent holder and then
into a rat quadrature body coil. Temperature and respir-
ation were monitored during the imaging procedure.
While under anesthesia and immediately after nerve
injury, animals received an intravenous USPIO injection
(300 μmol/kg IV; mean particle size of 20 nm) with or
without minocycline (50 mg/kg IP QD, Sigma-Aldrich,
St. Louis, MO). Additional doses of USPIO were admi-
nistered 24 hours prior to MR imaging. Animals were
imaged at post-operative day 7. A FIESTA (Fast Imaging
Employing Steady State Acquisition) sequence, with TE/
TR/FA of 11/22/20, slice thickness of 1 mm and in plane
resolution of 0.11 x 0.11 mm was used. Using Osirix
image analysis software, regions of interest were circled
on bilateral sciatic nerves to quantify signal intensity,
which was then normalized to background signal in the
muscle.
Pain behavior measurements
A logarithmic series of calibrated monofilaments (Von Frey
hairs; Stoelting, Wood Dale, IL) were applied to the left and
right hindpaws to determine the threshold stiffness
required for 50% paw withdrawal. Log stiffness of the hairs
is defined as log10(milligrams x 10) and ranged from 3.61
(407 mg) to 5.18 (15,136 mg). The log stiffness that would
have resulted in a 50% paw withdrawal rate was computed
by fitting a Gaussian integral psychometric function to the
Figure 4 Histology verifies MR imaging findings with perineural iron-laden macrophages demonstrated only in animals injected with
USPIOs without minocycline. Paraffin sections were prepared from the distal segment of the nerve, just proximal to the ligature, and stained
with (A, C, E, G) hematoxylin and eosin (H&E) to provide morphological detail and with (B, D, F, H) Perl’s stain, which stains iron blue. (A, B)
Control (−USPIO) longitudinal sections through the neuroma and surrounding perineural tissue harvested from the site of the neuroma show no
iron staining. (C-F) Tissues harvested from SNI animals injected with USPIOs. At 200X magnification, the axial section and the longitudinal section
(C, D) and an axial section (E, F) from a different animal show areas of increased iron staining in the perineural tissues. These iron containing cells
demonstrate histologic characteristics of macrophages. At 200x magnification, iron and H&E stained axial sections from animals treated with
minocycline and USPIOs (+MINO-USPIO) show localization of iron containing cells to the perineural tissue, albeit to a qualitatively lesser extent
than the –MINO+USPIO treated sections.
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hairs using a maximum likelihood fitting method that
allows parametric statistical analysis.
Histology
Extracted intact sciatic nerves proximal to the site of liga-
ture were harvested after the animal was euthanized on day
7 after imaging. Samples were fixed and stained either with
hematoxylin and eosin, or with Perl’s stain for iron per
standard protocols.Statistical analysis
Data were analyzed by one-way ANOVA performed on
GraphPad Prism (San Diego, CA), with p value <0.05
accepted as significant.
Abbreviations
MRI: Magnetic resonance imaging; USPIO: Ultrasmall paramagnetic iron-oxide
; SPIO: Superparamagnetic iron-oxide; MINO: Minocycline; FIESTA: Fast
imaging employing steady state acquisition.
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